Khiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America. The Company has filled medical cannabis prescriptions in Colombia, Peru, Germany and the United Kingdom. To date, the Company has trained nearly 1,000 medical professionals in Latin America and the UK.
Khiron is the only company from Latin America participating in Project Twenty 21, Europe’s largest observational study of medical cannabis products. Leveraging wholly-owned medical clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure.